Buprenorphine Transdermal Patch bulk supplier for pharma manufacturers

Buprenorphine Transdermal Patch Suppliers & Bulk Manufacturers

Available Forms: Transdermal Patch

Available Strengths: 5 mcg/hr, 10 mcg/hr, 15 mcg/hr, 20 mcg/hr

Reference Brands: Butrans(US)

Buprenorphine transdermal patches activate mu-opioid receptors, blocking pain signals and altering pain perception for sustained relief. Benefits include long-lasting, effective pain control, improved patient adherence due to convenience, and a lower risk of overdose compared to other opioids when used responsibly and monitored carefully.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Buprenorphine transdermal patches are approved in both the EU and US for managing severe pain. In the EU, brands like Butrans are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and rigorous manufacturing standards. In the US, FDA approval is based on extensive clinical data; generics are also available. Both regions enforce strict regulations, including prescribing controls and pharmacovigilance due to the potential for abuse. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for buprenorphine patches, ensuring adherence to European and American standards for safe, effective pain management in opioid-tolerant patients.

Buprenorphine Transdermal Patch — third party manufacturing & bulk supply

Buprenorphine Transdermal Patch is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Buprenorphine Transdermal Patch is supplied as Transdermal Patch — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Buprenorphine Transdermal Patch listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Buprenorphine Transdermal Patch →

Back to Listing

Frequently Asked Questions

Buprenorphine Transdermal Patch is used for the management of moderate to severe chronic pain that requires continuous, long-term opioid treatment. It delivers a controlled dose of buprenorphine through the skin over several days.

It is made from buprenorphine, a semi-synthetic opioid, embedded in a transdermal system that releases the drug steadily through the skin into the bloodstream.

The commonly known trade names are Butrans and Transtec.

Butrans is marketed by Purdue Pharma / Collegium Pharmaceutical in some regions, while Transtec is produced by Grünenthal. Several companies also manufacture generic patches.

The generic name is buprenorphine transdermal system (buprenorphine).

The well-known brand names include Butrans and Transtec.

It is manufactured in various countries including India, the USA, and several European regions by both branded and generic pharmaceutical manufacturers.